Valutazione attuale: 0 / 5

Stella inattivaStella inattivaStella inattivaStella inattivaStella inattiva
 
  • Aldenhoven M, Boelens JJ, de Koning TJ.The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant 2008
  • Aldenhoven M, de Koning TJ, Verheijen FW, et al. Dried blood spot analysis: An easy and reliable tool to monitor the biochemical eect of Hematopoietic stem cell transplantation in Hurler syndrome patients. Biol Blood Marrow Transplantation 2010
  • Beesley CE, Meaney CA, Greenland G, et al. Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identication of 17 novel mutations and in vitro expression of missense mutations. Hum Genet. 2001
  • Bijarnia S, Shaw P, Vimpani A. Combined enzyme replacement and haematopoietic stem cell Transplantation in Hurler syndrome. J Paediatr Child Health 2009
  • Bjoraker KJ, Delaney K, Peters C, Krivit W, Shapiro EG. Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler Syndrome) treated with hematopoietic stem cell transplantation. J Dev Behav Pediatr 2006
  • Boelens JJ. Trends in haematopoietic cell transplantation for inborn errors of metabolism. J Inherit Metab Dis 2006
  • Boelens JJ, Wynn RF, O'Meara A, et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 2007
  • Boelens JJ, Rocha V, Aldenhoven M, et al on behalf of EUROCORD, Inborn Error Working Party of EBMT and Duke University. Risk Factor Analysis of Outcomes after Unrelated Cord Blood Transplantation in Patients with Hurler Syndrome. Biol Blood Marrow Transplant 2009
  • Braunlin EA, Rose AG, Hopwood JJ, et al. Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the Hurler syndrome. Am J Cardiol 2001
  • Braunlin EA, Stauer NR, Peters CH, et al. Usefulness of bone marrow transplantation in the Hurler syndrome. Am J Cardiol.2003
  • Braunlin EA, Berry JM, Whitley CB. Cardiac ndings after enzyme replacement therapy for Mucopolysaccharidosis type I. Am J Cardiol 2006
  • Church H, Tylee K, Cooper A, et al. Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease. Bone Marrow Transplant 2007
  • Cox-Brinkman J, Smeulders MJ, Hollak CE, Wijburg FA. Restricted upper extremity range of motion in mucopolysaccharidosis type I: no response to one year of enzyme replacement therapy. J Inherit Metab Dis 2007
  • Dionisi-Vici C, Rizzo C, Burlina AB et al. Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. J Pediatr 2002
  • Dusing SC, Thorpe D, Rosenberg A, et al. Gross motor abilities in children with Hurler syndrome. Dev Med & Child Neurol 2006
  • Gaipa G, Dassi M, Perseghin P et al. Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases. Bone marrow Transplant 2003
  • Gassas A, Sung L, Doyle JJ, Clarke JT, Saunders EF. Life-threatening pulmonary hemorrhages post bone marrow transplantation in Hurler syndrome. Report of three cases and review of the literature. Bone Marrow Transplant 2003
  • Grainger J, Wynn R, Carr T, Wraith E, et al. Stem cell transplantation for mucopolysaccharidoses type 1, Hurler's disease  Results at 5 years follow-up from a single center. Bone Marrow Transplant 2002
  • Grewal SS, Krivit W, Defor TE et al. Outcome of second hematopoietic cell transplantation in Hurler syndrome. Bone marrow Transplant 2002
  • Grewal SS, Wynn R, Abdenur JE et al. Safety and ecacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome. Genet Med 2005
  • Grigull L, Beilken A, Schrappe1 M, et al.Transplantation of allogeneic CD34- selected stem cells after udarabinebased conditioning regimen for children with mucopolysaccharidosis 1H (M.Hurler). Bone Marrow Transplant 2005
  • Haddad FS, Jones DH, Vellodi A, Kane N, Pitt MC. Carpal tunnel syndrome in the mucopolysaccharidoses and mucolipidoses. J Bone Joint Surg Br 1997
  • Hansen MD, Filipovich AH, Davies SM, et al. Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen. Bone Marrow Transplant 2008
  • Hobbs JR, Hugh-Jones K, Barrett AJ, et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981
  • Hulsebos RG, Zeebregts CJ, de Langen ZJ. Perforation of a congenital umbilical hernia in a patient with Hurler's syndrome. J Pediatr Surg 2004
  • Kakavanos R, Turner CT, Hopwood JJ, Kakkis ED, Brooks DA. Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I. Lancet 2003
  • Kakkis ED, Muenzer J, Tiller GE, et al. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 2001
  • Khan SA, Sehat K., Calthorpe D. Cervical cord compression in an elderly patient with Hurler's syndrome: a case report. Spine 2003
  • Khanna G, Van Heest AE, Agel1 J, et al. Analysis of factors aecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantation. Bone Marrow Transplant 2007
  • Kharbanda S, Panoskaltsis-Mortari A, Haddad IY, et al. Inammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders. Biol Blood Marrow Transplant 2006
  • Krivit W, Lockman LA, Watkins PA, Hirsch J, Shapiro EG. The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy, and Hurler syndrome. J Inherit Metab Dis 1995
  • Loberiza FR Jr, Serna DS, Horowitz MM, Rizzo JD. Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know? Bone Marrow Transplant 2003
  • Lowry RB, Renwick DH. Relative frequency of the Hurler and Hunter syndromes. N Engl J Med. 1971
  • Lücke T, Das AM, Hartmann H, et al. Developmental outcome in ve children with Hurler syndrome after stem cell transplantation:a pilot study. Dev Med Child Neurol 2007
  • Malone BN, Whitley CB, Duvall AJ, et al. Resolution of obstructive sleep apnea in Hurler syndrome after bone marrow transplantation. Int J Pediatr Otorhinolaryngo. 1988
  • Martin PL, Carter SL, Kernan NA, et al. Results of the Cord Blood Transplantation Study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 2006
  • Martins AM, Dualibi AP, Norato D, et al. Guidelines for the management of mucopolysaccharidosis type I. J Pediatr. 2009
  • Masterson EL, Murphy PG, O'Meara A, et al. Hip dysplasia in Hurler's syndrome: orthopaedic management after bone marrow transplantation. J Pediatr Orthop 1996
  • Matheus MG, Castillo M, Smith JK, Armao D, Towle D, Muenzer J. Brain MRI ndings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 2004
  • Messina C, Rampazzo A, Cesaro S, et al. Eighteen-year follow-up of the rst Italian MPSI patient treated with bone marrow transplantation. Bone Marrow Transplant 2008
  • Moore D, Connock MJ, Wraith JE, Lavery C. The prevalence of and survival in mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK. Orphanet J Rare Dis.2008
  • Muenzer J, Wraith JE, Clarke LA and the International Consensus Panel on the Management and Treatment of Mucopolysaccharidosis I. Mucopolysaccharidosis I: Management and Treatment Guidelines. Pediatrics.2009
  • Munoz-Rojas MV, Vieira T, Costa R, et al. Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression. Am J Med Genet A 2008
  • Nettesheim S, Link B, Wendt S, Schulze-Frenking G, Beck M. Musculoskeletal manifestations and orthopaedic problems in patients with mucopolysaccharidosis: an overview. Acta Pædiatrica 2006
  • Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Molecular and Metabolic Basis of Inherited Disease. New York, NY: McGraw-Hill; 2001
  • Odunusi E, Peters C, Krivit W, et al. Genu valgum deformity in Hurler syndrome after hematopoietic stem cell transplantation: correction by surgical intervention. J Pediatr Orthop 1999
  • Orchard PJ, Milla C, Braunlin E, et al. Pre-transplant risk factors aecting outcome in Hurler syndrome. Bone Marrow Transplant 2010
  • Pastores GM, Meere PA. Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I). Curr Opin Rheumatol 2005
  • Peters C, Balthazor M, Shapiro EG et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996
  • Peters C, Shapiro EG, Krivit W. Hurler syndrome: past, present, and future. J Pediatr. 1998
  • Peters C, Shapiro EG, Anderson J, et al. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fty-four children. The Storage Disease Collaborative Study Group. Blood 1998
  • Peters C. Hematopoietic cell transplantation for storage diseases: In: Donnell Thomas G, Blume KG and Forman SJ (eds). Hematopoietic Stem Cell Transplantation, Malden, MA: Blackwell Science, 1999
  • Peters C, Steward CG. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant 2003
  • Pitt C, Lavery C, Wager N. Psychosocial outcomes of bone marrow transplant for individuals aected by Mucopolysaccharidosis I Hurler Disease: patient social competency. Child: care, health dev 2009
  • Polgreen LE, Tolar J, Plog M, et al. Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation. Bone Marrow Transplant 2008
  • Polgreen LE, Plog M, Schwender JD,et al. Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation. Bone Marrow Transplant 2009
  • Prasad VK, Mendizabal A, Parikh SH et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: inuence of cellular composition of the graft on transplantation outcomes. Blood 2008
  • Prasad VK, Kurtzberg J. Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant 2009
  • Prasad VK, Kurtzberg J. Cord blood and bone marrow transplantation in inherited metabolic diseases: scientic basis, current status and future directions. Br J Haematol 2010
  • Prasad VK, Kurtzberg J. Transplant Outcomes in Mucopolysaccharidoses. Semin Hematol 2010
  • Pyeritz RE. Cardiovascular manifestations of heritable disorders of connective tissue. In: Steinberg AG, Bearn AG, Motulsky AG, Childs B (eds). Progress in Medical Genetics. Philadelphia, PA: Saunders; 1983
  • Scott HS, Guo XH, Hopwood JJ, Morris CP. Structure and sequence of the human alpha-L-iduronidase gene. Genomics. 1992
  • Scott HS, Litjens T, Nelson PV, et al. Identication of mutations in the alpha- L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes. Am J Hum Genet. 1993
  • Scott HS, Bunge S, Gal A, et al. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. Hum Mutat.1995
  • Shapiro J, Strome M, Crocker AC. Airway obstruction and sleep apnea in Hurler and Hunter syndromes. Ann Otol Rhinol Laryngol 1985
  • Shinhar SY, Zablocki H, Madgy DN. Airway management in mucopolysaccharide storage disorders. Arch Otolaryngol Head Neck Surg 2004
  • Soni S, Hente M, Breslin N, Hersh J. Pre-stem cell transplantation enzyme replacement therapy in Hurler syndrome does not lead to signicant antibody formation or delayed recovery of the endogenous enzyme post-transplant: A case report. Pediatr Transplantation 2007
  • Souillet G, Guon N, Maire I, et al. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant 2003
  • Staba S, Escolar M, Poe M, et al. Cord blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004
  • Terlato NJ, Cox GF. Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature. Genet Med. 2003
  • Tolar J, Grewal SS, Bjoraker KJ, et al. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. Bone Marrow Transplant 2008
  • Tolar J, Orchard PJ, Key NS, Blazar BR. Circulating anticoagulant glycosaminoglycans in mucopolysaccharidosis type I. J Thromb Haemost 2008
  • Tolar J, Orchard PJ. -L-iduronidase therapy for mucopolysaccharidosis type I. Biologics.2008
  • Vellodi A, Young EP, Cooper A, et al. Bone marrow transplantation for mucopolysaccharidosis typeI: experience with two British centres. Arch Dis Child 1997
  • Venturi N, Rovelli A, Parini R, et al. Molecular analysis of 30 mucopolysaccharidosis type I patients: evaluation of the mutational spectrum in Italian population and identication of 13 novel mutations. Hum Mutat 2002
  • Weibel TD, Brady RO. Systematic approach to the diagnosis of lysosomal storage diseases. Ment Retard Dev Disabil Res Rev. 2001
  • Whitley CB, Belani KG, Chang PN, et al. Long-term outcome of Hurler syndrome following bone marrow transplantation. Am J Med Gene. 1993
  • Wraith JE, Alani SM. Carpal tunnel syndrome in the mucopolysaccharidoses and related disorders. Arch Dis Child 1990
  • Wraith JE. The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child. 1995
  • Wraith JE. Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging diculties. J Inherit Metab Dis 2001
  • Wraith JE, Clarke LA, Beck M et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, doubleblinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 2004
  • Wynn RF, Mercer J, Page J, Carr TF, Jones S, Wraith JE. Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 Patients. J Pediatr. 2009
  • Wynn RF, Wraith JE, Mercer J, et al. Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy. J Pediatr. 2009

 

Indice
 
INTRODUZIONE
 
  1. Le Mucopolisaccaridosi: Epidemiologia; Clinica; Indagini Diagnostiche; Neuroimmagini; Aspetti Neurobiologici; Terapia Enzimatica; Plasticità Neuronale: gli studi; Associazione Italiana Mucopolisaccaridosi A.I.MPS
  2. Mucopolisaccaridosi I: Manifestazioni Cliniche; Trapianto di Cellule Staminali Ematopoietiche
  3. Caso Clinico: Controlli Periodici; Trattamento Riabilitativo; Valutazione Neuropsicologica; Profilo di Sviluppo e Trattameno
  4. Ictus e Plasticità Neuronale: Ictus; Plasticità Neuronale; Meccanismi d'Azione della Plasticità; Plasticità in seguito ad una Lesione; Plasticità a Distaza della Lesione; Plasticità del Cervello nel Recupero Post Ictus; Plasticità Crossmodale
  5. Riabilitazione Neuromotoria: Programmi di Riabilitazione Neurologica; Meccanismi di Recupero; Tecniche di Riapprendimento Funzionale; Ogni Terapia è Simultaneamente Neuro e Psicomotoria; Nuovi Approcci, Nuovi Canali
 
CONCLUSIONI
 
BIBLIOGRAFIA
 
Tesi di Laurea di: Dèsirée FRAGNELLI